Strategic Early Development Asset Lead

Biopharma Careers; Greater London; Hybrid; GBP 120,000 - 150,000; Full time

Job summary

Ipsen Biopharm Ltd in the United Kingdom is seeking an Early Development Asset Lead (EDAL) to drive scientific and program leadership for one or more early-stage assets. You will lead the Early Development Asset Team (EDT) spanning clinical, regulatory, CMC and translational activities, ensuring rigorous strategy and accountable portfolio decisions.

The EDAL will align with Therapeutic Area strategy, championing assigned programs, articulating goals and scientific rationale, and representing the

Responsibilities

• Leads one or more Early Development Asset Teams.
• Owns integrated program strategy across preclinical, translational, clinical, diagnostic and regulatory activities.
• Develops integrated asset strategy including target product profile and portfolio decisions.

Job description

Ipsen Biopharm Ltd in the United Kingdom is seeking an Early Development Asset Lead (EDAL) to drive scientific and program leadership for one or more early-stage assets. You will lead the Early Development Asset Team (EDT) spanning clinical, regulatory, CMC and translational activities, ensuring rigorous strategy and accountable portfolio decisions.

The EDAL will align with Therapeutic Area strategy, championing assigned programs, articulating goals and scientific rationale, and representing the